Actively Recruiting
The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group
Led by Liaquat National Hospital & Medical College · Updated on 2026-03-06
60
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction
CONDITIONS
Official Title
The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 4-16 years
- Both genders
- Myopia with baseline spherical equivalent refraction of -1.00 diopters or more
- Astigmatism less than or equal to -2.50 diopters
- No medical history predisposing to severe myopia such as Marfan syndrome, Stickler syndrome, or retinopathy of prematurity
- No abnormal ocular refractive anatomy like keratoconus, lenticonus, or spherophakia
- No history of vision-threatening ocular diseases or previous intraocular surgery
- No current or previous use of atropine, pirenzipine, contact lenses, or other treatments affecting myopia progression
You will not qualify if you...
- Astigmatism greater than or equal to 2.5 diopters
- Anisometropia greater than 1 diopter
- Best corrected visual acuity less than 0.5 (6/12)
- Prior intraocular surgery
- Allergy to atropine eye drops
- Systemic diseases associated with myopia such as Marfan syndrome or Stickler syndrome
- History of cardiac or significant respiratory diseases
- Lack of consent for participating in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
LiaquatNHMC
Karachi, Sindh, Pakistan
Actively Recruiting
Research Team
H
Hina Nadeem, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here